$0.7800
-0.04-4.88%
At close: -
Comments
Loading...
Medicenna Therapeutics Stock Price, Quotes and Forecasts
MDNAFOTCQX
Medicenna Therapeutics (MDNAF) Forecast
NewsEarningsMedicenna Therapeutics (MDNAF) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Medicenna Therapeutics Stock Price, Quotes and Forecasts | OTC:MDNAF | Benzinga
Explore Medicenna Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDNAF.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Medicenna Therapeutics (MDNAF) stock?
You can purchase shares of Medicenna Therapeutics (OTCQX:MDNAF) through any online brokerage.
Who are Medicenna Therapeutics (MDNAF) competitors?
There are no as such competitors for Medicenna Therapeutics.
What is the forecast, or price target, for Medicenna Therapeutics (MDNAF) stock?
There is no analysis for Medicenna Therapeutics to provide a consensus price target.
What is the current price for Medicenna Therapeutics (MDNAF)?
The stock price for Medicenna Therapeutics (OTCQX: MDNAF) is $0.78 last updated April 21, 2025 at 3:59 PM EDT.
Does Medicenna Therapeutics (MDNAF) pay a dividend?
There are no upcoming dividends for Medicenna Therapeutics.
When is Medicenna Therapeutics (OTCQX:MDNAF) reporting earnings?
Medicenna Therapeutics does not have any upcoming earnings scheduled.
Is Medicenna Therapeutics (MDNAF) going to split?
There is no upcoming split for Medicenna Therapeutics.
What sector and industry does Medicenna Therapeutics (MDNAF) operate in?
Medicenna Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQX.
